Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export andsupplier ofCladribine Injectionfrom Surat, Gujarat, India. Cladribine Injection used to treat hairy cellleukemia (HCL, leukemic reticuloendotheliosis) and B-cell chronic lymphocyticleukemia.
Tags: Cladribine Injection manufacturer, Cladribine Injection exporter,Cladribine Injection supplier, and Cladribine Injection, whogmp approved Cladribine Injectionmanufacturer and supplier, Cladribine Injection distributor, Cladribine Injectionshipper, Cladribine Injection 10 ml Cladribine Injection 10 mlsupplier,Cladribine Injection 10 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inGujarat, India.
Registration: Saintroy Lifescienceis interested inregistration of own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy LifescienceCladribine Injection Exportto USA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal,Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Therapeutic Uses and IndicationsCladribine Injection is approved for the treatment of Hairy Cell Leukemia, Multiple Sclerosis, and a range of lymphoproliferative disorders. Its efficacy in reducing abnormal cell growth makes it a valuable option in specific oncological and immunological scenarios when prescribed by a qualified physician.
Safety Standards and Quality AssuranceManufactured under strict GMP guidelines, this injection meets stringent safety and quality requirements. Each vial delivers a standardized 10 mg/ml dose of Cladribine in a neutral pH solution, ensuring consistency across every batch for healthcare institutions, wholesalers, and distributors.
Proper Storage and HandlingTo preserve its integrity and potency, Cladribine Injection should be stored in a cool, dry environment. The packaging prevents contamination and ensures that the solution remains clear and free from particulate matter or discoloration throughout its two-year shelf life.
FAQ's of Cladribine Injection:
Q: How should Cladribine Injection be administered?
A: Cladribine Injection is administered as an intravenous infusion. Prior to administration, it must be further diluted with normal saline according to the dilution instructions provided in the prescribing information. The process should only be conducted by qualified healthcare professionals in a controlled clinical setting.
Q: What are the main indications for Cladribine Injection?
A: Cladribine Injection is primarily used for the treatment of Hairy Cell Leukemia, Multiple Sclerosis, and other lymphoproliferative disorders. It is prescribed when other treatments are inadequate or when specifically indicated by a physician.
Q: When should Cladribine Injection not be used?
A: This medication is contraindicated in patients with a known hypersensitivity to Cladribine or any of its excipients. It should also be used with caution in individuals with hepatic or renal impairment, and only under the supervision of a healthcare provider.
Q: Where should Cladribine Injection be stored to maintain its efficacy?
A: To ensure maximum shelf life and efficacy (up to two years), Cladribine Injection should be stored in a cool, dry place away from direct sunlight. Always check the vial before use for any particulate matter or discoloration.
Q: What precautions should be considered before using Cladribine Injection?
A: Cladribine should be used cautiously in patients with hepatic or renal impairment. Physicians must evaluate patient history and monitor closely throughout the treatment course to mitigate any potential adverse effects.
Q: What are the benefits of using Cladribine Injection in indicated conditions?
A: Cladribine Injection offers effective disease control for certain cancers and autoimmune disorders by targeting and reducing abnormal cell proliferation. Its use can lead to remission or symptom improvement when administered as part of a comprehensive treatment strategy.
Q: How is the quality and safety of Cladribine Injection ensured?
A: This product is GMP-certified, meaning it is produced under stringent manufacturing standards that guarantee quality, sterility, and proper composition with every batch, whether distributed locally or exported internationally.